US$ 29.14
l carnitine prostate cancer Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways l carnitine androgen receptor Drug
Description
In: Floh L., Harris J.R., editors

The triple action leads to enhanced fat burning, improved glucose control, and better liver metabolism

Not for clinical, therapeutic, or diagnostic use

It can promote the secretion of growth hormone, enhance the function of the immune system, and improve the cognitive ability of the brain

Annu Rev Pharmacol Toxicol 53:5987

In 2001, mutation of fumarate hydratase leading to its inactivation was discovered in renal cell cancer 129
